USANA HEALTH SCIENCES, INC.
Income Statement
| Line Item | FY2016 | FY2015 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|
| Revenue | $1.01B | $790.5M | $718.2M | $648.7M | $581.9M | $436.9M |
| Cost of Revenue | $180.2M | $140.8M | $127.4M | $115.8M | $101.7M | $89.8M |
| Gross Profit | $825.9M | $649.7M | $590.7M | $532.9M | $480.2M | $347.1M |
| Gross Margin | 82.1% | 82.2% | 82.3% | 82.1% | 82.5% | 79.4% |
| Operating Expenses | ||||||
| Research & Development | $8.8M | $5.1M | $5.1M | $4.7M | $4.1M | — |
| SG&A Expense | $234.2M | $184.5M | $166.2M | $154.2M | $137.1M | $100.0M |
| Operating Income | $138.6M | $116.1M | $116.7M | $98.2M | $77.3M | $50.8M |
| Operating Margin | 13.8% | 14.7% | 16.3% | 15.1% | 13.3% | 11.6% |
| Interest Expense | $444.0K | $129.0K | $1.0K | $20.0K | $9.0K | $609.0K |
| Pretax Income | $138.6M | $115.7M | $116.6M | $98.4M | $77.5M | $51.0M |
| Income Tax Expense | $38.5M | $39.0M | $37.6M | $32.0M | $26.7M | $17.4M |
| Net Income | $100.0M | $76.6M | $79.0M | $66.4M | $50.8M | $33.6M |
| Net Margin | 9.9% | 9.7% | 11.0% | 10.2% | 8.7% | 7.7% |
| EPS (Basic) | $4.14 | $2.90 | $5.77 | $4.57 | $3.30 | $2.19 |
| EPS (Diluted) | $3.99 | $2.80 | $5.56 | $4.45 | $3.26 | $2.17 |
| Shares Outstanding (Basic) | 24.2M | 26.4M | 13.7M | 14.5M | 15.4M | 15.3M |
| Shares Outstanding (Diluted) | 25.0M | 27.4M | 14.2M | 14.9M | 15.6M | 15.4M |
| Dividends Per Share | — | — | — | — | — | — |